Goldman Sachs analyst maintained a Hold rating on Ascletis Pharma, Inc. yesterday and set a price target of HK$15.71. The company’s shares clos...
Ascletis Pharma, Inc. (1672) Gets a Hold from Goldman Sachs
Goldman Sachs analyst maintained a Hold rating on Ascletis Pharma, Inc. yesterday and set a price target of HK$15.71. The company’s shares clos...